Combining its genomic data with de-identified claims data from BHI has helped Concert Genetics shine a bright light on unnecessary coding variations and price disparities in the genetic health information network.
The demand for genetic testing is dynamic and difficult for payers to discern. Using the BHI claims data along with their own data, Concert Genetics watches trends and helps payers adapt their policies and procedures to the changing landscape.
Concert Genetics will continue to do all it can to make the genetic health information network easier, faster, and more usable. The company’s partnership with BHI is a big part of its plans.